LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Product Launches ANI Pharmaceuticals, Inc. has recently introduced new products like Ketoconazole Shampoo, Promethazine Hydrochloride, and Dextromethorphan Hydrobromide Oral Solution. These launches present sales opportunities to cater to evolving consumer needs.

Strategic Acquisitions The acquisition of Alimera Sciences, Inc. signifies ANI's expansion strategy. Leveraging the acquired company's assets can open up new markets and increase sales potential for ANI Pharmaceuticals.

Financial Investment With a substantial financial investment of $325 million into new assets, ANI Pharmaceuticals is poised for growth. This infusion can fuel sales initiatives and support business development efforts.

Product Diversification ANI's commitment to launching diverse products like Naproxen Delayed-Release Tablets and generic drug Kionex shows a focus on market diversification. This variety can attract different customer segments, expanding sales avenues.

Market Expansion through Legal Action Despite legal action from Alimera Sciences, ANI Pharmaceuticals has an opportunity to counter and capitalize on this situation. Adapting sales strategies to navigate challenges can lead to market expansion and increased revenue.

Similar companies to ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. Tech Stack

ANI Pharmaceuticals, Inc. uses 8 technology products and services including Akamai, Drupal, web-vitals, and more. Explore ANI Pharmaceuticals, Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • Drupal
    Content Management System
  • web-vitals
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Microsoft Teams
    Team Collaboration
  • VMware
    Virtualisation Software
  • Apache HTTP Server
    Web Servers
  • Linkedin
    Widgets

Media & News

ANI Pharmaceuticals, Inc.'s Email Address Formats

ANI Pharmaceuticals, Inc. uses at least 1 format(s):
ANI Pharmaceuticals, Inc. Email FormatsExamplePercentage
First.Last@anipharmaceuticals.comJohn.Doe@anipharmaceuticals.com
90%
FLast@anipharmaceuticals.comJDoe@anipharmaceuticals.com
5%
Last@anipharmaceuticals.comDoe@anipharmaceuticals.com
4%
Last.First@anipharmaceuticals.comDoe.John@anipharmaceuticals.com
1%

Frequently Asked Questions

Where is ANI Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc.'s main headquarters is located at 500 Alexander Park Princeton, New Jersey 08540 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is ANI Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact ANI Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ANI Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is ANIP.

What is ANI Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc.'s official website is anipharmaceuticals.com and has social profiles on LinkedIn.

How much revenue does ANI Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of August 2024, ANI Pharmaceuticals, Inc.'s annual revenue reached $750M.

What is ANI Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 446110 - Pharmacies and Drug Stores.

How many employees does ANI Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2024, ANI Pharmaceuticals, Inc. has approximately 501 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: M. P.Chief Compliance Officer And Head Of Legal, Rare Disease: E. P.Vice President & Chief Financial Officer: C. A.. Explore ANI Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does ANI Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does ANI Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc.'s tech stack includes AkamaiDrupalweb-vitalsWebpackMicrosoft TeamsVMwareApache HTTP ServerLinkedin.

What is ANI Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
ANI Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more ANI Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has ANI Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2024, ANI Pharmaceuticals, Inc. has raised $275M in funding. The last funding round occurred on Aug 07, 2024 for $275M.
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

Pharmaceutical ManufacturingNew Jersey, United States501-1000 Employees

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com. 

Section iconCompany Overview

Headquarters
500 Alexander Park Princeton, New Jersey 08540 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ANIP
NAICS Code
446110 - Pharmacies and Drug Stores
Employees
501-1000

Section iconFunding & Financials

  • $275M

    ANI Pharmaceuticals, Inc. has raised a total of $275M of funding over 4 rounds. Their latest funding round was raised on Aug 07, 2024 in the amount of $275M.

  • $100M$1B

    ANI Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $275M

    ANI Pharmaceuticals, Inc. has raised a total of $275M of funding over 4 rounds. Their latest funding round was raised on Aug 07, 2024 in the amount of $275M.

  • $100M$1B

    ANI Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.